U.S. govt boosts Moderna COVID-19 vaccine contract to $1.25 bln

Moderna Inc said on Wednesday the U.S. government had agreed to increase the contract for the company's COVID-19 vaccine by $236 million to roughly $1.25 billion, to include additional costs related to the shot's studies. The company and the Biomedical Advanced Research and Development Authority (BARDA) had initially signed a $483 million deal for the vaccine in July last year, which was later increased to about $1 billion.

Moderna Inc said on Wednesday the U.S. government had agreed to increase the contract for the company's COVID-19 vaccine by $236 million to roughly $1.25 billion, to include additional costs related to the shot's studies.

The company and the Biomedical Advanced Research and Development Authority (BARDA) had initially signed a $483 million deal for the vaccine in July last year, which was later increased to about $1 billion. As of March 31, 2021, the remaining available funding net of revenue earned under the BARDA Contract, prior to the increased payment, was $317 million, Moderna said in a regulatory filing. (https://bit.ly/3eBLcEf0)

The U.S. government in August last year had also separately signed a $1.53 billion deal for 100 million doses of the Moderna vaccine, with an option to buy 400 million more doses. Moderna's two-dose vaccine is one of the three COVID-19 vaccines authorized for use in the United States. Nearly 30%, or 96.7 million Americans have been fully vaccinated as of April 27, according to data from the U.S. Centers for Disease Control and Prevention.

(This story has not been edited by Devdiscourse staff and is auto-generated from a syndicated feed.)